# Efficacy of MitraCLip Vs. PASCAL for the TrEAtment of MitraL REgurgiTation in an All-comer Population

Study · id `cardio:ct-nct06634121` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06634121](<https://clinicaltrials.gov/study/NCT06634121>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06634121

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 180 participants.

## Technical summary

Registry record NCT06634121. Randomized; no masking; primary purpose treatment. Start 2024-04-01 (actual); primary completion 2027-04-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 180 participants (planned count; ClinicalTrials.gov record NCT06634121, source copy `cardio:ctgov-nct06634121-2024-10-09`, retrieved 2026-10-26)
- Started: 2024-04-01 (actual) (ClinicalTrials.gov record NCT06634121, source copy `cardio:ctgov-nct06634121-2024-10-09`, retrieved 2026-10-26)
- Primary completion: 2027-04-01 (anticipated) (ClinicalTrials.gov record NCT06634121, source copy `cardio:ctgov-nct06634121-2024-10-09`, retrieved 2026-10-26)
- Completion: 2028-04-01 (anticipated) (ClinicalTrials.gov record NCT06634121, source copy `cardio:ctgov-nct06634121-2024-10-09`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT06634121, source copy `cardio:ctgov-nct06634121-2024-10-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06634121-2024-10-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy of MitraCLip Vs. PASCAL for the TrEAtment of MitraL REgurgiTation in an All-comer Population
- Acronym: LEAFLET I
- Condition: Mitral Regurgitation
- Condition: Valvular Heart Disease
- Condition: Heart Failure
- Intervention (Device): Transcatheter mitral valve edge-to-edge repair (M-TEER)
- Lead sponsor: LMU Klinikum
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as the lead sponsor: LMU Klinikum (`cardio:org-lmu-klinikum`)

## Provenance

Content hash: 36d899514f0f0b7cd16a26c9bd2c8a322b2590c7f370008bae4e63c82e3c2265
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
